Scott Capital Advisors, LLC Pfizer Inc Transaction History

Scott Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$32.09 - $37.51 $10,461 - $12,228	326 Added 5.56%	6,191 $205,000
Q2 2023 Jul 11, 2023	BUY	$36.12 - $41.79 $5,309 - $6,143	147 Added 2.57%	5,865 $215,000
Q1 2023 Apr 12, 2023	SELL	$39.39 - $51.28 $1,890 - $2,461	-48 Reduced 0.83%	5,718 $233,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $19,455 - $25,397	-466 Reduced 7.48%	5,766 $0
Q3 2022 Oct 14, 2022	BUY	$43.76 - $53.42 $175 - $213	4 Added 0.06%	6,232 $273,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $40,341 - $47,832	867 Added 16.17%	6,228 $327,000
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $245,265 - $303,915	5,361 New	5,361 $278,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Scott Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Scott Capital Advisors, LLC with notifications on news.